• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hypothyroidism-induced kidney dysfunction: an under-recognized phenomenon in patients on immune checkpoint inhibitors.

作者信息

Tan Hui Zhuan, Zhu Ling, Chan Jack Junjie, Rajasekaran Tanujaa D/O, Choo Jason Chon Jun

机构信息

Department of Renal Medicine, Singapore General Hospital, Central Region, Singapore.

Department of Endocrinology, Singapore General Hospital, Central Region, Singapore.

出版信息

Clin Kidney J. 2022 Feb 11;15(7):1431-1433. doi: 10.1093/ckj/sfac043. eCollection 2022 Jul.

DOI:10.1093/ckj/sfac043
PMID:35756745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9217634/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0331/9217634/d05e0ec8a03e/sfac043fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0331/9217634/d05e0ec8a03e/sfac043fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0331/9217634/d05e0ec8a03e/sfac043fig1.jpg

相似文献

1
Hypothyroidism-induced kidney dysfunction: an under-recognized phenomenon in patients on immune checkpoint inhibitors.甲状腺功能减退引起的肾功能障碍：免疫检查点抑制剂治疗患者中一种未被充分认识的现象。
Clin Kidney J. 2022 Feb 11;15(7):1431-1433. doi: 10.1093/ckj/sfac043. eCollection 2022 Jul.
2
Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment.免疫检查点抑制剂治疗后的甲状腺免疫相关不良事件。
J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3704-e3713. doi: 10.1210/clinem/dgab263.
3
Association between the type of thyroid dysfunction induced by immune checkpoint inhibitors and prognosis in cancer patients.免疫检查点抑制剂引起的甲状腺功能障碍的类型与癌症患者预后的关系。
BMC Endocr Disord. 2022 Apr 4;22(1):89. doi: 10.1186/s12902-022-01004-8.
4
Immune Checkpoint Inhibitor-related New-onset Thyroid Dysfunction: A Retrospective Analysis Using the US FDA Adverse Event Reporting System.免疫检查点抑制剂相关新发甲状腺功能障碍：使用美国 FDA 不良事件报告系统进行的回顾性分析。
Oncologist. 2022 Mar 4;27(2):e126-e132. doi: 10.1093/oncolo/oyab043.
5
A decrease in peripheral thyroid hormone conversion efficiency in patients treated with immune checkpoint inhibitors and L-T3 as a possible alternative therapeutic escape option.免疫检查点抑制剂治疗患者外周甲状腺激素转化效率降低，L-T3 可能是一种替代治疗逃逸选择。
Eur J Clin Invest. 2022 Jul;52(7):e13790. doi: 10.1111/eci.13790. Epub 2022 Apr 21.
6
Two distinct clinical patterns of checkpoint inhibitor-induced thyroid dysfunction.检查点抑制剂诱导的甲状腺功能障碍的两种不同临床模式。
Endocr Connect. 2020 Apr;9(4):318-325. doi: 10.1530/EC-19-0473.
7
Thyroid disorders associated with immune control point inhibitors.与免疫检查点抑制剂相关的甲状腺疾病。
Endocrinol Diabetes Nutr (Engl Ed). 2021 Jun-Jul;68(6):408-415. doi: 10.1016/j.endien.2021.10.004. Epub 2021 Oct 21.
8
Pembrolizumab-induced hypothyroidism caused reversible increased serum creatinine levels: a case report.帕博利珠单抗导致的甲状腺功能减退症引起血清肌酐水平可逆性升高：一例报告。
BMC Nephrol. 2020 Mar 31;21(1):113. doi: 10.1186/s12882-020-01775-z.
9
Characterization and implications of thyroid dysfunction induced by immune checkpoint inhibitors in real-life clinical practice: a long-term prospective study from a referral institution.免疫检查点抑制剂诱导的甲状腺功能障碍的临床特征及其影响：来自一家转诊机构的长期前瞻性研究。
J Endocrinol Invest. 2018 May;41(5):549-556. doi: 10.1007/s40618-017-0772-1. Epub 2017 Oct 17.
10
Immune Checkpoint Inhibitor-induced Thyroid Dysfunction Is Associated with Higher Body Mass Index.免疫检查点抑制剂引起的甲状腺功能障碍与较高的体重指数有关。
J Clin Endocrinol Metab. 2020 Oct 1;105(10). doi: 10.1210/clinem/dgaa458.

本文引用的文献

1
Immune checkpoint inhibitor-induced thyroiditis is a risk factor for acute and chronic kidney dysfunction.免疫检查点抑制剂诱发的甲状腺炎是急性和慢性肾功能不全的一个危险因素。
Nephrol Dial Transplant. 2021 Dec 31;37(1):187-189. doi: 10.1093/ndt/gfab240.
2
C-reactive protein as a biomarker for immune-related adverse events in melanoma patients treated with immune checkpoint inhibitors in the adjuvant setting.C-反应蛋白作为免疫检查点抑制剂辅助治疗黑色素瘤患者免疫相关不良事件的生物标志物。
Melanoma Res. 2021 Aug 1;31(4):371-377. doi: 10.1097/CMR.0000000000000748.
3
Checkpoint inhibitor therapy-associated acute kidney injury: time to move on to evidence-based recommendations.
检查点抑制剂治疗相关的急性肾损伤：是时候转向基于证据的建议了。
Clin Kidney J. 2021 Mar 10;14(5):1301-1306. doi: 10.1093/ckj/sfab052. eCollection 2021 May.
4
Biomarkers, Clinical Features, and Rechallenge for Immune Checkpoint Inhibitor Renal Immune-Related Adverse Events.免疫检查点抑制剂相关肾免疫不良反应的生物标志物、临床特征及再激发
Kidney Int Rep. 2021 Feb 2;6(4):1022-1031. doi: 10.1016/j.ekir.2021.01.013. eCollection 2021 Apr.
5
Pembrolizumab-induced hypothyroidism caused reversible increased serum creatinine levels: a case report.帕博利珠单抗导致的甲状腺功能减退症引起血清肌酐水平可逆性升高：一例报告。
BMC Nephrol. 2020 Mar 31;21(1):113. doi: 10.1186/s12882-020-01775-z.
6
C-reactive protein as an early marker of immune-related adverse events.C-反应蛋白作为免疫相关不良事件的早期标志物。
J Cancer Res Clin Oncol. 2019 Oct;145(10):2625-2631. doi: 10.1007/s00432-019-03002-1. Epub 2019 Sep 6.
7
The renal manifestations of thyroid disease.甲状腺疾病的肾脏表现。
J Am Soc Nephrol. 2012 Jan;23(1):22-6. doi: 10.1681/ASN.2010070766. Epub 2011 Oct 21.